To the full analysis
Edgewell Personal Care stock: growth
EPCEdgewell Personal Care reported $2B in revenue for fiscal 2026, down 10.2% on the prior year, down 0.9% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
−2.7%
per year from 2007 to 2026, per share −1.7%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | since 2007 | |
|---|---|---|---|
| Revenue | −0.9% | −1.7% | −2.7% |
| Revenue per share | 2.4% | 0.8% | −1.7% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2007 | $3.37B | $321.4M | $356.7M |
| 2008 | $4.33B | $329.3M | $306.5M |
| 2009 | $4B | $297.8M | $349.5M |
| 2010 | $4.25B | $403M | $543.7M |
| 2011 | $4.65B | $261.2M | $314.5M |
| 2012 | $4.57B | $408.9M | $520.6M |
| 2013 | $4.47B | $407M | $659.4M |
| 2014 | $4.45B | $356.1M | $486.7M |
| 2015 | $2.42B | −$275.3M | $49.4M |
| 2016 | $2.36B | $178.7M | $106.9M |
| 2017 | $2.3B | $5.7M | $227.2M |
| 2018 | $2.23B | $103.3M | $202.7M |
| 2019 | $2.14B | −$372.2M | $132.6M |
| 2020 | $1.95B | $67.6M | $184.9M |
| 2021 | $2.09B | $117.8M | $172.2M |
| 2022 | $2.17B | $99.5M | $45.6M |
| 2023 | $2.25B | $114.7M | $166.6M |
| 2024 | $2.25B | $98.6M | $174.5M |
| 2025 | $2.22B | $25.4M | $41.4M |
| 2026 | $2B | −$51.7M | −$10M |
Revenue by segment
How Edgewell Personal Care Company makes its money and how that has shifted. Names are as the company reports them.
- Razors and blades50%
- Sun care products21%
- Tampons, Pads and Liners12%
- Infant Care and Other Products9%
- Shaving gels and creams5%
- Wipes and other skin care products4%
- Other< 1%
“Other” combines smaller and former segments with revenue the company does not assign to a segment. Names as reported, with abbreviations spelled out for the largest companies.
Figures as a table
| 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|
| Razors and blades | $1.1B | $1.11B | $1.1B | 49.7% |
| Sun care products | $450.7M | $483.6M | $458.9M | 20.6% |
| Tampons, Pads and Liners | $315.2M | $283.6M | $261.5M | 11.8% |
| Infant Care and Other Products | $172.5M | $182.9M | $200.6M | 9% |
| Shaving gels and creams | $127.3M | $118.3M | $114.2M | 5.1% |
| Wipes and other skin care products | no data | no data | $83.6M | 3.8% |
| Other | $82.3M | $74.3M | $0 | 0% |
| Total revenue | $2.25B | $2.25B | $2.22B | 100% |
Revenue by region
Where Edgewell Personal Care Company generates its revenue.
- United States54%
- Outside the US46%
Figures as a table
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| United States | $1.33B | $1.25B | $1.19B | $1.08B | $1.18B | $1.31B | $1.33B | $1.26B | $1.2B | 54.2% |
| Outside the US | $967.9M | $988.6M | $951.8M | $866.9M | $903.7M | $865.2M | $925.5M | $991.9M | $1.02B | 45.8% |
| Total revenue | $2.3B | $2.23B | $2.14B | $1.95B | $2.09B | $2.17B | $2.25B | $2.25B | $2.22B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 30 Sep 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 23 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.